Diagnostic Medical Systems: Voting rights and shares as of July 31, 2026

On August 18, 2026, Diagnostic Medical Systems, listed on Euronext Growth Paris under the ticker symbol ALDMS, announced its share capital as of July 31, 2026. In compliance with legal requirements, the company disclosed that it had 26,686,791 shares outstanding. Regarding voting rights, the theoretical total is 30,806,939, while the exercisable voting rights amount to 29,995,583.

DMS Group has positioned itself as a major player in digital radiology, with a strong international presence. In 2025, it recorded a turnover of €50 million, the majority of which was generated abroad, thanks to a vast network of 140 distributors. The company is part of the ETIncelles program, which supports dynamic and ambitious SMEs.